Literature DB >> 3974200

Biochemical and microscopic evidence for the internalization and degradation of heparin-containing mast cell granules by bovine endothelial cells.

F M Atkins, M M Friedman, D D Metcalfe.   

Abstract

Incubation of [35S]heparin-containing mast cell granules with cultured bovine endothelial cells was followed by the appearance of 35S-granule-associated radioactivity within the endothelial cells and a decrease in radioactivity in the extracellular fluid. These changes occurred during the first 24 hours of incubation and suggested ingestion of the mast cell granules by the endothelial cells. Periodic electron microscopic examination of the monolayers confirmed this hypothesis by demonstrating apposition of the granules to the plasmalemma of endothelial cells, which was followed by the engulfment of the granules by cytoplasmic projections. Under light microscopic examination, mast cell granules within endothelial cells then appeared to undergo degradation. The degradation of [35S]heparin in mast cell granules was demonstrated by a decrease in the amount of intracellular [35S]heparin proteoglycan after 24 hours and the appearance of free [35S]sulfate in the extracellular compartment. Intact endothelial cells were more efficient at degrading [35S]heparin than were cell lysates or cell supernatants. These data provide evidence of the ability of endothelial cells to ingest mast cell granules and degrade native heparin that is presented as a part of the mast cell granule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3974200

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Mast cell granule heparin proteoglycan induces lacunae in confluent endothelial cell monolayers.

Authors:  D Lagunoff; A Rickard
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Growth characteristics of a permanent human endothelial cell line.

Authors:  H I Schaefer; F M van 't Hooft; A van der Laarse
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

3.  The ultrastructure of mast cells in the uterus throughout the normal menstrual cycle and the postmenopause.

Authors:  L Drudy; B L Sheppard; J Bonnar
Journal:  J Anat       Date:  1991-04       Impact factor: 2.610

4.  Central nervous system neurons acquire mast cell products via transgranulation.

Authors:  M Wilhelm; R Silver; A J Silverman
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

Review 5.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 6.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

7.  Oxidative degradation of rat mast-cell heparin proteoglycan.

Authors:  D D Metcalfe; H L Thompson; S J Klebanoff; W R Henderson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

8.  Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen.

Authors:  Alicia Prieto-García; Dominick Zheng; Roberto Adachi; Wei Xing; William S Lane; Kyungmee Chung; Paul Anderson; Philip M Hansbro; Mariana Castells; Richard L Stevens
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

9.  Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.

Authors:  J O Kokkonen; P T Kovanen
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

10.  Mouse Bone Marrow-Derived Mast Cells Induce Angiogenesis by Tissue Engineering in Rats: Histological Evidence.

Authors:  Ali Karimi; Rasoul Shahrooz; Rahim Hobbenaghi; Rahim Mohammadi; Esmaeil Mortaz
Journal:  Cell J       Date:  2017-11-04       Impact factor: 2.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.